Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil · Delayed Price · Currency is BRL 0.5900
-0.0100 (-1.67%)
Aug 6, 2026, 5:05 PM GMT-3
BVMF:ONCO3 Balance Sheet
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 112.1 | 509.55 | 550.74 | 550.7 | 263.21 | 536.84 |
Short-Term Investments | 0.19 | 0.74 | 1,338 | 210.72 | 829.59 | - |
Trading Asset Securities | - | 2.43 | 32.19 | - | - | 1,478 |
Cash & Short-Term Investments | 112.29 | 512.71 | 1,921 | 761.42 | 1,093 | 2,015 |
Cash Growth | -93.22% | -73.30% | 152.23% | -30.32% | -45.76% | 155.97% |
Accounts Receivable | 1,462 | 1,490 | 2,049 | 1,857 | 1,380 | 666.15 |
Other Receivables | 269.72 | 238.67 | 279.78 | 190.72 | 142.6 | 47.78 |
Receivables | 1,732 | 1,729 | 2,329 | 2,048 | 1,522 | 713.93 |
Inventory | 136.38 | 185.48 | 225.24 | 206.39 | 163.94 | 69.41 |
Other Current Assets | 489.08 | 469.39 | 186.19 | 89.69 | 47.87 | 73.13 |
Total Current Assets | 2,470 | 2,896 | 4,661 | 3,105 | 2,827 | 2,871 |
Property, Plant & Equipment | 1,077 | 1,103 | 1,336 | 1,235 | 1,091 | 727.55 |
Long-Term Investments | 88.83 | 85.89 | 179.9 | 143.16 | 34.37 | 37.27 |
Goodwill | 1,439 | 1,439 | 2,405 | 2,670 | 2,569 | 1,169 |
Other Intangible Assets | 1,214 | 1,244 | 1,346 | 1,521 | 1,345 | 1,069 |
Long-Term Accounts Receivable | - | - | 385.58 | - | - | - |
Long-Term Deferred Tax Assets | 187.4 | 159.39 | 508.09 | 392.58 | 223.43 | 33.42 |
Other Long-Term Assets | 208.67 | 157.95 | 360.97 | 106.28 | 97.78 | 93.22 |
Total Assets | 6,700 | 7,131 | 11,202 | 9,181 | 8,220 | 6,032 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,186 | 1,097 | 1,020 | 795.4 | 604.79 | 427.34 |
Accrued Expenses | 254.15 | 204.24 | 333.01 | 219.04 | 200.82 | 149.04 |
Current Portion of Long-Term Debt | 3,332 | 3,232 | 756.26 | 407.03 | 349.97 | 358.47 |
Current Portion of Leases | 50.63 | 48 | 57.83 | 67.22 | 64.17 | 37.47 |
Current Income Taxes Payable | 58.29 | 46.62 | 54.75 | 62.25 | 4.55 | 19.87 |
Other Current Liabilities | 469.31 | 573.91 | 231.83 | 265.52 | 658.99 | 198.54 |
Total Current Liabilities | 5,350 | 5,202 | 2,453 | 1,816 | 1,883 | 1,191 |
Long-Term Debt | - | 109.34 | 4,276 | 3,750 | 2,769 | 1,810 |
Long-Term Leases | 457.99 | 464.98 | 503.37 | 345.13 | 304.66 | 232.2 |
Long-Term Deferred Tax Liabilities | 75.29 | 74.67 | 41.19 | 21.64 | 6.39 | 5.94 |
Other Long-Term Liabilities | 195.25 | 217.18 | 546.32 | 568.47 | 623.91 | 488.69 |
Total Liabilities | 6,079 | 6,068 | 7,820 | 6,502 | 5,587 | 3,727 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 4,408 | 4,562 | 3,147 | 2,455 | 2,250 | 2,207 |
Retained Earnings | -4,699 | -4,335 | -711.06 | -64.87 | -288.49 | -334.75 |
Treasury Stock | -87.57 | -87.57 | -94.47 | -103.7 | -79.4 | -20.62 |
Comprehensive Income & Other | 912.32 | 761.78 | 804.86 | 15.09 | 235.96 | 2.25 |
Total Common Equity | 533.37 | 900.93 | 3,146 | 2,301 | 2,118 | 1,854 |
Minority Interest | 87.63 | 161.48 | 236.08 | 378.15 | 514.67 | 450.93 |
Shareholders' Equity | 621 | 1,062 | 3,382 | 2,679 | 2,632 | 2,305 |
Total Liabilities & Equity | 6,700 | 7,131 | 11,202 | 9,181 | 8,220 | 6,032 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,840 | 3,854 | 5,593 | 4,569 | 3,488 | 2,438 |
Net Cash (Debt) | -3,728 | -3,342 | -3,673 | -3,808 | -2,395 | -423.3 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.98 | -3.86 | -5.96 | -7.11 | -4.50 | -1.03 |
Filing Date Shares Outstanding | 1,118 | 1,118 | 632.79 | 508.28 | 478.21 | 474.78 |
Total Common Shares Outstanding | 1,118 | 1,118 | 632.79 | 508.28 | 478.21 | 474.78 |
Working Capital | -2,880 | -2,306 | 2,208 | 1,289 | 943.55 | 1,681 |
Book Value Per Share | 0.48 | 0.81 | 4.97 | 4.53 | 4.43 | 3.90 |
Tangible Book Value | -2,119 | -1,781 | -604.17 | -1,889 | -1,797 | -384.4 |
Tangible Book Value Per Share | -1.90 | -1.59 | -0.95 | -3.72 | -3.76 | -0.81 |
Land | 5.22 | 5.22 | - | - | - | - |
Machinery | 523.87 | 522.23 | - | - | - | - |
Construction In Progress | 121.54 | 113.21 | - | - | - | - |
Leasehold Improvements | 563.69 | 568.59 | - | - | - | - |